FACTS ABOUT KINASE INHIBITOR-1 REVEALED

The phylogenetic map from the human kinome demonstrating progress and US FDA acceptance of small molecule kinase inhibitors to tyrosine kinases and serine/threonine kinases for various stable and hematologic malignancies.The impressive outcomes demonstrated with imatinib mesylate (aka Gleevec) concentrating on break position cluster (Bcr)-Abelson (